Tyler J Nelson
Overview
Explore the profile of Tyler J Nelson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Liu H, Williamson C, Zou J, Todd J, Nelson T, Hill L, et al.
Oral Oncol
. 2022 Nov;
136:106247.
PMID: 36410204
Objective: To determine characteristics most strongly associated with risk for aspiration events among head and neck cancer (HNC) patients undergoing curative intent treatment. Materials And Methods: This was a retrospective,...
12.
Bryant A, Nelson T, McKay R, Kader A, Parsons J, Einck J, et al.
BJUI Compass
. 2022 May;
3(3):243-250.
PMID: 35492227
Objective: To analyse the effect of age at diagnosis on clinical outcomes of localized prostate cancer (PCa) treated with radiation therapy. Subjects And Methods: We identified 12 784 patients with...
13.
Javier-Desloges J, Nelson T, Murphy J, McKay R, Stewart T, Kader A, et al.
Urol Oncol
. 2022 Apr;
40(5):199.e15-199.e21.
PMID: 35431133
Objectives: To determine the representation of women, minorities, and the elderly groups in clinical trials and whether participation has changed over time. Methods: Retrospective study in the National Cancer Institute...
14.
Kotha N, Kumar A, Nelson T, Qiao E, Qian A, Voora R, et al.
Urol Oncol
. 2022 Feb;
40(6):274.e1-274.e6.
PMID: 35216893
Background: The coronavirus disease 2019 (COVID-19) pandemic has raised concerns about delaying treatment for localized cancer and its impact on long-term outcomes. Objective: We aimed to investigate the impact of...
15.
Nelson T, Thompson C, Zou J, Kumar A, Sangchan P, Williamson C, et al.
Cancer
. 2022 Feb;
128(10):1948-1957.
PMID: 35194791
Background: To test whether nomograms developed by NRG Oncology for oropharyngeal squamous cell carcinoma (OPSCC) patients could be validated in an independent population-based sample. Methods: The authors tested nomograms for...
16.
Williamson C, Nelson T, Thompson C, Vitzthum L, Zakeri K, Riviere P, et al.
Clin Cancer Res
. 2022 Feb;
28(9):1832-1840.
PMID: 35140122
Purpose: Cancer treatments can paradoxically appear to reduce the risk of noncancer mortality in observational studies, due to residual confounding. Here we introduce a method, Bias Reduction through Analysis of...
17.
Courtney P, Deka R, Kotha N, Cherry D, Salans M, Nelson T, et al.
J Natl Compr Canc Netw
. 2022 Feb;
20(2):151-159.
PMID: 35130495
Background: Active surveillance (AS) is a safe treatment option for men with low-risk, localized prostate cancer. However, the safety of AS for patients with intermediate-risk prostate cancer remains unclear. Patients...
18.
Kotha N, Kumar A, Nelson T, Qiao E, Qian A, Voora R, et al.
Adv Radiat Oncol
. 2022 Jan;
7(1):100836.
PMID: 35071834
Purpose: Chemoradiation (CRT) is a definitive treatment option for muscle-invasive bladder cancer (MIBC). Despite its effectiveness, CRT is underused, in part owing to concerns of tolerability and the need for...
19.
Qiao E, Lynch J, Lee K, Kotha N, Nalawade V, Voora R, et al.
J Natl Cancer Inst
. 2021 Dec;
114(4):592-599.
PMID: 34893859
Background: Despite higher risks associated with prostate cancer, young African American men are poorly represented in prostate-specific antigen (PSA) trials, which limits proper evidence-based guidance. We evaluated the impact of...
20.
Sherer M, Deka R, Salans M, Nelson T, Sheridan P, Rose B
Prostate Cancer Prostatic Dis
. 2021 Nov;
26(2):276-281.
PMID: 34811501
Background: Androgen deprivation therapy (ADT) is frequently utilized in conjunction with radiotherapy (RT) in the definitive management of prostate cancer. Prior studies have suggested an association between ADT use and...